On the margins of World Health Assembly that took place in Geneva last week and beginning this week, ReAct together with Dag Hammarskjöld Foundation and South Centre organized an event on antibiotic resistance. Hosted at the UNAIDS "Health Innovation Exchange Marketplace’" the event focused on the launch of the report: When the Drugs Don’t Work: Antibiotic Resistance as a Global Development Problem that ReAct and Dag Hammarskjöld Foundation published earlier this year.
Earlier this year, ReAct and Dag Hammarskjöld Foundation published the report When the Drugs Don’t Work: Antibiotic Resistance as a Global Development Problem. The report presents concrete examples on how antibiotic resistance is jeopardizing the achievement of many of the Sustainable Development Goals and why it must be addressed as a development problem. In a conversation between ReAct Europe’s Andreas Sandgren, ReAct Africa’s Mirfin Mpundu, the moderator Viviana Muñoz-Tellez from the South Centre, and the audience, the content of the report was discussed. The conversation also covered the challenges that countries are facing in their work to address antibiotic resistance.
Work on ABR will help global development and system strengthening
Andreas Sandgren, Policy Advisor, ReAct Europe, stressed that there was a missed opportunity to include antibiotic resistance in the SDGs targets and indicators and therefore we are racing against time. However, with antibiotics starting to lose their effectiveness due to resistant infections, its alarming effects are far-reaching for the development of societies, and unless decisive and rapid action is taken globally and systematically it will only get worse. For this purpose, viewing antibiotic resistance as a development problem, there are also opportunities to find solutions in addressing it through the work on global development and system strengthening.
Centrally positioned focal point for ABR to help implement NAP on AMR
Mirfin Mpundu, Head of ReAct Africa, identified the importance of a centrally positioned focal point for antibiotic resistance. This person, with a designated role to coordinate the work on antibiotic resistance across sectors, can carry forward the work of not only developing a National Action Plan (NAP), but also coordinate the implementation of it. In many countries this is missing due to lack of financial means, and at large there is a lack of costed and financed National Action Plans. Therefore, there is a need to mobilize domestic and global support, both technical and financial, to move this critical work forward.
Leave no-one behind
Incorporating an antibiotic resistance perspective in the national development agenda, can be one of the means to work on strengthening national systems, that will work towards the goals of both reaching the SDGs and addressing the antibiotic resistance problem. The theme of the World Health Assembly this year was Universal Health Coverage: leaving no-one behind. Achieving Universal Health Coverage is directly linked to access to safe, effective, quality and affordable essential medicines and vaccines for all. Given the global distribution of infectious diseases, the emergence of antibiotic resistance creates bottleneck for establishing universal health coverage globally, and no health system will be sustainable without effective antibiotics.
When the Drugs Don’t Work: Antibiotic Resistance as a Global Development Problem
This report by ReAct and Dag Hammarskjöld Foundation looks at the state of global development when the drugs don’t work and a post-antibiotic era sets in. The report shows how antibiotic resistance is a global development problem by highlighting existing data and people’s experiences. When the Drugs Don’t Work – Antibiotic Resistance as a Global Development Problem (4,1 MB, PDF).
More news and opinion
- Dr Yoel Lubell, Health Economist, on Thailand, AMR, UCH and cultural factors driving AMR
- UHC and AMR: The Thai Experience
- Why do effective antibiotics matter for quality of care and patient safety?
- New ReAct policy brief: Antimicrobial resistance and universal health coverage – What’s the deal?
- Three key takeaways from the ReAct Africa conference
- Diagnostics: Species identification
- AMR-specific indicator proposed for monitoring Sustainable Development Goals
- Five focus areas at the 2nd Ministerial Conference on AMR hosted by the Netherlands
- Safety concerns of fecal microbiota transplants
- Upcoming ReAct Africa Conference: universal health coverage and antimicrobial resistance in focus
- Mother Earth conference in Argentina – the environment in focus
- Diagnostics: What are we talking about?
- Connecting global to local civil-society-agenda on AMR at CSO convening in Geneva
- ReAct colleagues featured in WHO Bulletin as leading profiles in the work on reacting to antibiotic resistance
- RAN stakeholder at WHO IPC consultation – for standards and guidelines in African Union member states
- WHA conversation on Antibiotic Resistance as a Global Development Problem co-organized by ReAct
- 8 insights from ReAct Asia Pacific project on antibiotic stewardship in secondary level hospitals in India
- Open letter to UN Member States from former IACG members Anthony So and Otto Cars
- ReAct UHC Intervention at UNGA Multi-stakeholder Hearing for High-level Meeting on UHC
- ReAct Latin America honors Earth Day
- Medicines Patent Pool’s view on the role of licenses for antibiotics – World Intellectual Property Day
- Second time for Innovate4AMR competition!
- World Health Day 2019: Universal Health Coverage
- Diagnostics: Constraints for successful implementation
- Antibiotic Shortages: magnitude, causes and possible solutions: A new WHO meeting report
- Erry Setyawan, FAO, on Indonesian NAP: We need to work together to make it possible to manage AMR
- ReAct’s new 5-year strategic plan receives funding from Sida
- How infections spread and how to stop them
- Generating data for policy and practice